-
CSR Summary Not Available
-
NCT01394991
-
Primary Citation Not Yet Available
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameEpoetin alfaProduct NamePROCRIT®Therapeutic AreaBlood and Lymph ConditionsEnrollment504% FemaleN/A% WhiteN/A
Product ClassHematologic AgentsSponsor Protocol NumberEPOANE4008Data PartnerJohnson & JohnsonCondition StudiedAnemia, NeoplasmsMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available